Home Neoplasma 2011 Neoplasma Vol.58, No.2, p.104-109, 2011

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.58, No.2, p.104-109, 2011

Title: Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis
Author: L. JIA, X. F. YI, Z. B. ZHANG, Z. P. ZHUANG, J. LI, S. K. CHAMBERS, B. H. KONG, W. ZHENG

Abstract:

The exact role of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in ovarian epithelial carcinoma (OEC) development has not been yet characterized. This prompted us to identify particular proteins to better understand the underlying mechanism. Total proteins from ovarian epithelial tumor (OET) cells treated with gonadotropins were analyzed by proteomics. Western blot and immunohistochemistry were used to validate the target protein (prohibitin) and to detect its expression in human ovarian tissue of serous tumors. As the results, prohibitin was found to be significantly up-regulated by LH, with a maximum of 2.5-fold increase at the concentration of 200 mIU/mL.

The expression of prohibitin was steadily decreased from benign serous cystadenomas to borderline tumors and serous carcinomas (P < 0.0001). The difference between any two groups was significant (P < 0.001). Collectively, data from this study indicate that prohibitin is one LH-associated protein and it may be protective of ovarian cancer development and progression, supporting that LH may play an inhibitory role in ovarian tumorigenesis.



Keywords: Gonadotropin; Luteinizing hormone; Prohibitin; Ovarian cancer
Year: 2011, Volume: 58, Issue: 2 Page From: 104, Page To: 109
doi:10.4149/neo_2011_02_104


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.